Lululemon Stock Slides 43% in 2026, Lower Valuation Fails to Solve Growth Woes
Lululemon Athletica (LULU), S&P 500 endeksindeki en kötü performansı sergileyen hisselerden biri olarak 2026 yılında yüzde 43'lık bir düşüş yaşıyor. H
Lululemon Athletica (LULU) has emerged as one of the S&P 500's worst-performing stocks in 2026, with shares plunging 43%. While the selloff has made its valuation more attractive, the company continues to struggle with reviving growth in North America. Intensifying competition, margin pressure, and underwhelming product launches are weighing on the business, casting doubt on whether the recent decline alone makes LULU a buying opportunity. First-quarter results showed a 4% YoY revenue increase, surpassing Wall Street expectations, but comparable sales fell 2%, signaling underlying consumer demand weakness. North America remains the weakest link, with revenue down 3% and comparable sales dropping 6%, while Mainland China posted a 30% revenue surge and 13% comparable sales growth, though partially driven by Chinese New Year timing. The Rest of World segment also rose 13%. However, management struck a cautious tone for Q2, citing softer demand, negative media sentiment, and disappointing product launches. The company revised its outlook, now projecting Q2 revenue of $2.45B-$2.48B (a 2-3% YoY decline) and full-year 2026 guidance of $11.0B-$11.15B, down from $11.35B-$11.5B. These headwinds underscore the challenges of sustaining growth in a maturing athleisure market and highlight the risks of global supply chain disruptions and shifting consumer preferences.
Related News & Analysis
View All →
Moderna's Cancer Vaccine Euphoria Hits Profit-Taking Wall: $18 Billion Wipeout

Singh Joins Mayfield: A New Era for Chip Investments

Ramp Unveils Model Router, Steering the AI Landscape into a New Era

WNBA’s Landmark Pay Raise: 364% Surge in Player Wages Sparks Labor Milestone

Gen Z Rewrites the American Dream in the Great Postponement

Inertia Enterprises Cuts Fusion Fuel Loading to Hours, Shaking the Energy Market
Latest Market News
All News →
Moderna's Cancer Vaccine Euphoria Hits Profit-Taking Wall: $18 Billion Wipeout
Moderna’s Personalized mRNA Gamble: Oncology Revolution or Market Bubble?
![[GSRAY] GALATASARAY SPORTİF SINAİ VE TİCARİ YATIRIMLAR A.Ş.
Transfer Görüşmelerinin Sonuçlanması veya Sona Ermesi - Profesyonel Futbolcu Aleksei Batrakov Transferi Hakkında](/_next/image?url=%2Fuploads%2Fkap-default.png&w=3840&q=75)
[GSRAY] GALATASARAY SPORTİF SINAİ VE TİCARİ YATIRIMLAR A.Ş. Transfer Görüşmelerinin Sonuçlanması veya Sona Ermesi - Profesyonel Futbolcu Aleksei Batrakov Transferi Hakkında

Norway’s July Oil Production Slump Sends Shockwaves Through European Energy Markets

XRP's Post‑Election Best Week and Bitcoin Short Squeeze Shake the Crypto Market
